Application 212957
- Type
- ANDA
- Sponsor
- NAVINTA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE | POWDER;INTRAVENOUS | EQ 150MG BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70710-1615 | fosaprepitant | fosaprepitant | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1615 | fosaprepitant | fosaprepitant | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1615 | fosaprepitant | fosaprepitant | Zydus Pharmaceuticals USA Inc. | ANDA | Current |